Share information
263.90 €
+2.01 %
17/04/2026 17:39
+2.01 %
Open
High
Low
Volume
255.00 €
263.90 €
255.00 €
296,448
Latest News
17-Apr-2026
UCB to acquire Neurona Therapeutics, advancing its innovative leadership in epilepsy through regenerative science
17-Apr-2026
Acquisition of own shares
15-Apr-2026
UCB presents new data demonstrating quality-of-life impacts for epilepsy patients and caregivers at AAN 2026 meeting
10-Apr-2026
Acquisition of own shares